Abstract

Purpose

Although comprehensive and widespread guidelines on how to conduct systematic reviews of outcome measurement instruments (OMIs) exist, for example from the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative, key information is often missing in published reports. This article describes the development of an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline: PRISMA-COSMIN for OMIs 2024.

Methods

The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement.

Results

From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review’s title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts.

Conclusion

PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application.

Note

In order to encourage its wide dissemination this article is freely accessible on the web sites of the journals: Health and Quality of Life Outcomes; Journal of Clinical Epidemiology; Journal of Patient-Reported Outcomes; Quality of Life Research.

Details

Title
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024
Author
Elsman, Ellen B. M. 1   VIAFID ORCID Logo  ; Mokkink, Lidwine B. 2   VIAFID ORCID Logo  ; Terwee, Caroline B. 2   VIAFID ORCID Logo  ; Beaton, Dorcas 3   VIAFID ORCID Logo  ; Gagnier, Joel J. 4   VIAFID ORCID Logo  ; Tricco, Andrea C. 5   VIAFID ORCID Logo  ; Baba, Ami 6   VIAFID ORCID Logo  ; Butcher, Nancy J. 7   VIAFID ORCID Logo  ; Smith, Maureen 8   VIAFID ORCID Logo  ; Hofstetter, Catherine 9   VIAFID ORCID Logo  ; Aiyegbusi, Olalekan Lee 10   VIAFID ORCID Logo  ; Berardi, Anna 11   VIAFID ORCID Logo  ; Farmer, Julie 12   VIAFID ORCID Logo  ; Haywood, Kirstie L. 13   VIAFID ORCID Logo  ; Krause, Karolin R. 14   VIAFID ORCID Logo  ; Markham, Sarah 15   VIAFID ORCID Logo  ; Mayo-Wilson, Evan 16   VIAFID ORCID Logo  ; Mehdipour, Ava 17   VIAFID ORCID Logo  ; Ricketts, Juanna 18 ; Szatmari, Peter 14 ; Touma, Zahi 19   VIAFID ORCID Logo  ; Moher, David 20   VIAFID ORCID Logo  ; Offringa, Martin 21   VIAFID ORCID Logo 

 Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Department of Epidemiology and Data Science, Amsterdam, Netherlands (GRID:grid.16872.3a) (ISNI:0000 0004 0435 165X) 
 Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Department of Epidemiology and Data Science, Amsterdam, Netherlands (GRID:grid.16872.3a) (ISNI:0000 0004 0435 165X) 
 Institute of Work and Health, Toronto, Canada (GRID:grid.414697.9) (ISNI:0000 0000 9946 020X) 
 Western University, Department of Epidemiology and Biostatistics and Department of Surgery, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884) 
 Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Unity Health Toronto, Toronto, Canada (GRID:grid.415502.7); Dalla Lana School of Public Health, University of Toronto, Epidemiology Division and Institute of Health Policy, Management, and Evaluation, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); Queen’s Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen’s University, Kingston, Canada (GRID:grid.410356.5) (ISNI:0000 0004 1936 8331) 
 Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646) 
 Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Psychiatry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Cochrane Consumer Network, London, UK (GRID:grid.17063.33) 
 OMERACT Patient Research Partner, Toronto, Canada (GRID:grid.17063.33) 
10  University of Birmingham, Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
11  Sapienza University of Rome, Department of Human Neurosciences, Rome, Italy (GRID:grid.7841.a); IRCCS NEUROMED, Pozzilli, Italy (GRID:grid.419543.e) (ISNI:0000 0004 1760 3561) 
12  University of Toronto, Faculty of Dentistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
13  Warwick Research in Nursing, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK (GRID:grid.7372.1) (ISNI:0000 0000 8809 1613) 
14  University of Toronto, Cundill Centre for Child and Youth Depression, Centre for Addiction and Mental Health, Hospital for Sick Children, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
15  King’s College London, Department of Biostatistics and Health Informatics, Institute of Psychiatry Psychology and Neuroscience (IoPPN), London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
16  UNC Gillings School of Global Public Health, Department of Epidemiology, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208) 
17  McMaster University, School of Rehabilitation Science, Faculty of Health Sciences, Hamilton, Canada (GRID:grid.25073.33) (ISNI:0000 0004 1936 8227) 
18  Patient Partner, Halifax, Canada (GRID:grid.25073.33) 
19  Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Division of Rheumatology, Department of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
20  Ottawa Hospital Research Institute, Centre for Journalology, Clinical Epidemiology Program, Ottawa, Canada (GRID:grid.17063.33) (ISNI:0000 0004 0500 0659) 
21  Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Institute of Health Policy, Management and Evaluation, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
Pages
64
Publication year
2024
Publication date
Dec 2024
Publisher
Springer Nature B.V.
e-ISSN
25098020
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3076844049
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.